Efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer harboring ERBB2 exon 20 insertions and non-ERBB2 exon 20 insertions

被引：0
|
作者：
Tu, Hai-Yan
Kai Yin
Ke, E-E
Wu, Si-Pei
Zhao, Xiaotian
Li, Yang-Si
Zheng, Mei-Mei
Liu, Si-Yang Maggie
Sun, Yue-Li
Lin, Jia-Xin
Bai, Xiao-Yan
Zhang, Yi-Chen
Qing Zhou
Yang, Jin-Ji
Zhong, Wenzhao
Wang, Bin-Chao
Zhu, Dongqin
Yang, Lingling
Ou, Qiuxiang
Wu, Yi-Long
机构：
[1] South China Univ Technol, Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp,Sch Med, Guangzhou, Peoples R China
[2] Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci,Sch Clinical Med 2, Guangzhou, Peoples R China
[3] Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[4] Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangdong Prov Key Lab Translat Med Lung Canc, Guangzhou, Peoples R China
[5] Nanjing Geneseeq Technol Inc, Geneseeq Res Inst, Nanjing, Peoples R China
[6] Jinan Univ Chinese, Dept Hematol, Sch Med, Affiliated Hosp 1,Inst Hematol,Key Lab Regenerati, Jinan, Peoples R China
[7] Chinese Thorac Oncol Grp CTONG, Guangzhou, Peoples R China
[8] Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[9] Guangdong Acad Med Sci, Guangzhou, Peoples R China
[10] Guangdong Prov Peoples Hosp, Dept Guangdong Lung Canc Inst, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2591
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Targeting EGFR Exon 20 Insertions in Non-Small Cell Lung Cancer: Recent Advances and Clinical Updates
    Meador, Catherine B.
    Sequist, Lecia, V
    Piotrowska, Zofia
    CANCER DISCOVERY, 2021, 11 (09) : 2145 - 2157
  • [22] Systematic review and meta-analysis of immunotherapy effectiveness for pretreated patients with non-small cell lung cancer harboring EGFR exon 20 insertions
    Christopoulos, P.
    Ou, S-H. I.
    Lin, J.
    Berg, D.
    Hong, J-L.
    Yin, Y.
    Lin, J.
    Bunn, V.
    Lin, H. M.
    Mehta, M.
    Thomas, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S972 - S972
  • [23] Clinical Features, Outcomes, and Biology of EGFR exon 20 Insertions in a Cohort of Hispanic Patients with Non-small Cell Lung Cancer
    Motta, R.
    Cardona, A.
    Cruz, G.
    Aliaga, C.
    Carracedo, C.
    Raez, L.
    Arrieta, O.
    Mezquita, L.
    Albarran, V.
    Corrales, L.
    Bacon, L.
    Rojas, L.
    Zuluaga, J.
    Martin, C.
    Dabalsa, A.
    Ruiz-Patino, A.
    Freitas, H.
    Cordeiro, V.
    Failoc-Rojas, V.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S666 - S666
  • [24] Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib
    Yuan, Bo
    Zhao, Jun
    Zhou, Chengzhi
    Wang, Xiumei
    Zhu, Bo
    Zhuo, Minglei
    Dong, Xilin
    Feng, Jiemei
    Yi, Cuihua
    Yang, Yunpeng
    Zhang, Hua
    Zhou, Wangyan
    Chen, Zhengtang
    Yang, Sheng
    Ai, Xinghao
    Chen, Kehe
    Cui, Xuefan
    Liu, Difa
    Shi, Chunmei
    Wu, Wei
    Zhang, Yanjun
    Chang, Lianpeng
    Li, Jin
    Chen, Rongrong
    Yang, Shuanying
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [25] Efficacy of various types of chemotherapy for advanced non-small cell lung cancer with EGFR exon 20 in-frame insertions.
    Tang, Haibo
    Li, Xiaoning
    Cai, Jianhong
    Wu, Xiaomin
    Zheng, Yating
    Huang, Mengli
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Expression of ErbB2 and ErbB3 in Non-Small Cell Lung Cancer
    Salcedo, M. T.
    Montero, M. A.
    Hernandez-Losa, J.
    Teixido, C.
    Allende, H.
    Felip, E.
    Murtra-Garrell, N.
    Pallisa, E.
    Canela, M.
    Ramon y Cajal, S.
    Tallada, N.
    LABORATORY INVESTIGATION, 2012, 92 : 489A - 489A
  • [27] Expression of ErbB2 and ErbB3 in Non-Small Cell Lung Cancer
    Salcedo, M. T.
    Montero, M. A.
    Hernandez-Losa, J.
    Teixido, C.
    Allende, H.
    Felip, E.
    Murtra-Garrell, N.
    Pallisa, E.
    Canela, M.
    Ramon y Cajal, S.
    Tallada, N.
    MODERN PATHOLOGY, 2012, 25 : 489A - 489A
  • [28] Targeting EGFR exon 20 insertions in non-small cell lung cancer by exploiting a dependency on parallel SRC signalling
    Vyse, S.
    Chen, N.
    Oddy, J.
    Harrison, P.
    Le, A.
    Estrada-Bernal, A.
    Hermsen, M.
    Doebele, R.
    Huang, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer
    Brazel, Danielle
    Nagasaka, Misako
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 133 - 138
  • [30] Computationally predicted signatures of EGFR exon 20 insertions in non small cell lung cancer and its response to irreversible inhibitors
    Su, Bo-Han
    Huang, Derek
    Wang, Pei-Hua
    Lin, Olivia
    Tseng, Y. Jane
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
12345